AMN Healthcare Services (AMN)


Market Price (8/20/2026): $35.32 | Market Cap: $1.4 BilSector: Health Care | Industry: Health Care Services

AMN Healthcare Services (AMN)


Market Price (8/20/2026): $35.32
Market Cap: $1.4 Bil
Sector: Health Care
Industry: Health Care Services

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.3%, FCF Yield is 32%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%

Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include Telehealth Platforms, AI in Healthcare Management, Show more.

Trading close to highs
Dist 52W High is -3.5%

Weak multi-year price returns
2Y Excs Rtn is -74%, 3Y Excs Rtn is -132%

Stock price has recently run up significantly
6M Rtn6 month market price return is 107%

Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -5.5%

Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 92%

Key risks
AMN key risks include [1] a significant post-pandemic downturn in demand for temporary staffing, Show more.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.3%, FCF Yield is 32%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%
2 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include Telehealth Platforms, AI in Healthcare Management, Show more.
3 Trading close to highs
Dist 52W High is -3.5%
4 Weak multi-year price returns
2Y Excs Rtn is -74%, 3Y Excs Rtn is -132%
5 Stock price has recently run up significantly
6M Rtn6 month market price return is 107%
6 Weak revenue growth
Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -5.5%
7 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 92%
8 Key risks
AMN key risks include [1] a significant post-pandemic downturn in demand for temporary staffing, Show more.

AMN in ETFs

Weight = AMN's share of each fund

VTI0.00%
ITOT0.00%
IWM0.04%
IJR0.07%
IHF0.20%
SLYV0.14%
VIOV0.14%
IJS0.14%
+11 more covered ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 8/13/2026

AMN Healthcare Services (AMN) stock has gained about 75% since 4/30/2026 because of the following key factors:

1. Exceptional Financial Performance in Fiscal Q1 and Q2 2026. AMN Healthcare Services significantly surpassed analyst expectations in its fiscal Q1 2026 and Q2 2026 earnings reports. On May 7, 2026, the company announced fiscal Q1 2026 (ended March 31, 2026) adjusted diluted EPS of $2.10, beating the average analyst estimate of $1.60. This strong performance was driven by labor disruption events, growth in travel nursing, allied, and international nurse segments. Subsequently, for fiscal Q2 2026 (ended June 30, 2026), reported on August 6, 2026, AMN delivered an adjusted EPS of $0.77, considerably exceeding the consensus estimate of $0.19. Quarterly revenue for fiscal Q2 2026 also rose 2.3% year-over-year to $673.24 million, surpassing analyst estimates of $628.39 million. The company further provided a positive outlook, forecasting fiscal Q3 2026 revenue to be 1-3% higher year over year, with Nurse and Allied Solutions segment revenue expected to be up 9-11% year over year.

2. Robust Demand in Healthcare Staffing Industry. The company benefited from persistent strong demand across the healthcare staffing sector, particularly in travel nursing and allied health. Fiscal Q2 2026 results highlighted year-over-year growth in travel nursing and allied volume and revenue for the second consecutive quarter. Additionally, search revenue experienced a 27% year-over-year increase, with significant strength in executive search and physician permanent placement. A white paper released by AMN Healthcare on August 12, 2026, projected continued workforce strain across nursing, allied health, physicians, and advanced practitioners through 2030, reinforcing the long-term industry need for talent solutions.

Show more
Updated on 8/13/2026

AMN Healthcare Services (AMN) stock has gained about 75% since 4/30/2026 because of the following key factors:

1. Exceptional Financial Performance in Fiscal Q1 and Q2 2026. AMN Healthcare Services significantly surpassed analyst expectations in its fiscal Q1 2026 and Q2 2026 earnings reports. On May 7, 2026, the company announced fiscal Q1 2026 (ended March 31, 2026) adjusted diluted EPS of $2.10, beating the average analyst estimate of $1.60. This strong performance was driven by labor disruption events, growth in travel nursing, allied, and international nurse segments. Subsequently, for fiscal Q2 2026 (ended June 30, 2026), reported on August 6, 2026, AMN delivered an adjusted EPS of $0.77, considerably exceeding the consensus estimate of $0.19. Quarterly revenue for fiscal Q2 2026 also rose 2.3% year-over-year to $673.24 million, surpassing analyst estimates of $628.39 million. The company further provided a positive outlook, forecasting fiscal Q3 2026 revenue to be 1-3% higher year over year, with Nurse and Allied Solutions segment revenue expected to be up 9-11% year over year.

2. Robust Demand in Healthcare Staffing Industry. The company benefited from persistent strong demand across the healthcare staffing sector, particularly in travel nursing and allied health. Fiscal Q2 2026 results highlighted year-over-year growth in travel nursing and allied volume and revenue for the second consecutive quarter. Additionally, search revenue experienced a 27% year-over-year increase, with significant strength in executive search and physician permanent placement. A white paper released by AMN Healthcare on August 12, 2026, projected continued workforce strain across nursing, allied health, physicians, and advanced practitioners through 2030, reinforcing the long-term industry need for talent solutions.

3. Strategic Acquisitions and Partnerships for Growth. AMN Healthcare made several strategic moves within the period to expand its service offerings and leverage technology. In June 2026, the company acquired Jaide Health to enhance language access solutions through AI technology. Later that month, AMN acquired a Leadership Assessment Solution to strengthen its executive search and leadership advisory capabilities. Furthermore, a partnership with Brightfield was announced to advance workforce intelligence and market transparency for healthcare organizations. These initiatives demonstrate a commitment to strategic growth and technological integration in its solutions.

4. Positive Analyst Sentiment and Increased Price Targets. Following the strong financial results and strategic developments, analysts reacted positively by upgrading ratings and increasing price targets for AMN stock. For example, Truist Financial raised its target price on AMN Healthcare Services from $26.00 to $40.00 and reiterated a "buy" rating on July 22, 2026. UBS also raised its price target from $32 to $35. The average analyst rating for AMN Healthcare Services stock shifted towards "Buy" with an average price target that implied further upside, reflecting increased confidence in the company's future performance.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 72.5% change in AMN stock from 4/30/2026 to 8/19/2026 was primarily driven by a 38.2% change in the company's P/S Multiple.
(LTM values as of)43020268192026Change
Stock Price ($)20.4735.3272.5%
Change Contribution By: 
Total Revenues ($ Mil)2,7303,43425.8%
P/S Multiple0.30.438.2%
Shares Outstanding (Mil)3939-0.7%
Cumulative Contribution72.5%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 8/19/2026
ReturnCorrelation
AMN72.5% 
Market (SPY)7.0%13.7%
Sector (XLV)20.3%8.1%

Fundamental Drivers

The 65.8% change in AMN stock from 1/31/2026 to 8/19/2026 was primarily driven by a 32.5% change in the company's P/S Multiple.
(LTM values as of)13120268192026Change
Stock Price ($)21.3035.3265.8%
Change Contribution By: 
Total Revenues ($ Mil)2,7173,43426.4%
P/S Multiple0.30.432.5%
Shares Outstanding (Mil)3939-1.0%
Cumulative Contribution65.8%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 8/19/2026
ReturnCorrelation
AMN65.8% 
Market (SPY)11.4%16.8%
Sector (XLV)14.0%8.4%

Fundamental Drivers

The 92.6% change in AMN stock from 7/31/2025 to 8/19/2026 was primarily driven by a 62.9% change in the company's P/S Multiple.
(LTM values as of)73120258192026Change
Stock Price ($)18.3435.3292.6%
Change Contribution By: 
Total Revenues ($ Mil)2,8523,43420.4%
P/S Multiple0.20.462.9%
Shares Outstanding (Mil)3839-1.8%
Cumulative Contribution92.6%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 8/19/2026
ReturnCorrelation
AMN92.6% 
Market (SPY)22.7%17.5%
Sector (XLV)36.4%17.0%

Fundamental Drivers

The -67.0% change in AMN stock from 7/31/2023 to 8/19/2026 was primarily driven by a -61.5% change in the company's Net Income Margin (%).
(LTM values as of)73120238192026Change
Stock Price ($)107.1535.32-67.0%
Change Contribution By: 
Total Revenues ($ Mil)4,8173,434-28.7%
Net Income Margin (%)7.9%3.1%-61.5%
P/E Multiple11.613.113.2%
Shares Outstanding (Mil)41396.0%
Cumulative Contribution-67.0%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2023 to 8/19/2026
ReturnCorrelation
AMN-67.0% 
Market (SPY)73.9%20.6%
Sector (XLV)37.1%23.5%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
AMN Return79%-16%-27%-68%-34%119%-49%
Peers Return48%-19%14%17%-13%27%76%
S&P 500 Return27%-19%24%23%16%12%105%

Monthly Win Rates [3]
AMN Win Rate92%42%33%17%33%75% 
Peers Win Rate71%38%50%54%54%69% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
AMN Max Drawdown-23%-30%-48%-71%-45%-25% 
Peers Max Drawdown-20%-34%-24%-15%-25%-15% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: HSTM, KFY. See AMN Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/19/2026 (YTD)

How Low Can It Go

EventAMNS&P 500
2025 US Tariff Shock
  % Loss-25.4%-18.8%
  % Gain to Breakeven34.0%23.1%
  Time to Breakeven382 days79 days
2023 SVB Regional Banking Crisis
  % Loss-14.6%-6.7%
  % Gain to Breakeven17.1%7.1%
  Time to Breakeven50 days31 days
2022 Inflation Shock & Fed Tightening
  % Loss-29.6%-24.5%
  % Gain to Breakeven42.0%32.4%
  Time to Breakeven66 days427 days
2020 COVID-19 Crash
  % Loss-41.4%-33.7%
  % Gain to Breakeven70.7%50.9%
  Time to Breakeven290 days140 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-16.6%-3.7%
  % Gain to Breakeven19.9%3.9%
  Time to Breakeven7 days6 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-41.1%-12.2%
  % Gain to Breakeven69.7%13.9%
  Time to Breakeven88 days62 days

Compare to HSTM, KFY

In The Past

AMN Healthcare Services's stock fell -25.4% during the 2025 US Tariff Shock. Such a loss loss requires a 34.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventAMNS&P 500
2025 US Tariff Shock
  % Loss-25.4%-18.8%
  % Gain to Breakeven34.0%23.1%
  Time to Breakeven382 days79 days
2022 Inflation Shock & Fed Tightening
  % Loss-29.6%-24.5%
  % Gain to Breakeven42.0%32.4%
  Time to Breakeven66 days427 days
2020 COVID-19 Crash
  % Loss-41.4%-33.7%
  % Gain to Breakeven70.7%50.9%
  Time to Breakeven290 days140 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-41.1%-12.2%
  % Gain to Breakeven69.7%13.9%
  Time to Breakeven88 days62 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-58.0%-17.9%
  % Gain to Breakeven138.0%21.8%
  Time to Breakeven338 days123 days
2010 Eurozone Sovereign Debt Crisis / Flash Crash
  % Loss-37.1%-15.4%
  % Gain to Breakeven59.1%18.2%
  Time to Breakeven773 days125 days
2008-2009 Global Financial Crisis
  % Loss-73.0%-53.4%
  % Gain to Breakeven270.0%114.4%
  Time to Breakeven2064 days1085 days
Summer 2007 Credit Crunch
  % Loss-21.3%-8.6%
  % Gain to Breakeven27.1%9.5%
  Time to Breakeven2754 days47 days

Compare to HSTM, KFY

In The Past

AMN Healthcare Services's stock fell -25.4% during the 2025 US Tariff Shock. Such a loss loss requires a 34.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About AMN Healthcare Services (AMN)

AMN Healthcare Services, Inc. is a leading provider of comprehensive healthcare workforce solutions and staffing services to hospitals and healthcare facilities across the United States. Essentially, the company helps healthcare organizations meet their critical staffing needs by connecting them with a wide range of qualified medical professionals and offering services to optimize their workforce management.

The company's main services are delivered through three segments. Its Nurse and Allied Solutions segment supplies travel nurses, rapid response teams, and a variety of allied health professionals such as physical therapists, respiratory therapists, and medical technologists. The Physician and Leadership Solutions segment focuses on providing temporary physicians (locum tenens), interim leaders, and permanent placement services for doctors and executives. Lastly, the Technology and Workforce Solutions segment offers complementary services including language services, vendor management systems, workforce optimization tools, telehealth, and credentialing.

AMN Healthcare's primary customers are U.S. hospitals and healthcare facilities seeking to manage their staffing levels efficiently and access specialized talent. By offering a diverse portfolio of staffing, recruitment, and technology-enabled workforce solutions, AMN helps these facilities navigate fluctuating patient demands, address staff shortages, and improve overall operational effectiveness within the dynamic healthcare landscape.

AI Analysis | Feedback

Here are 1-2 brief analogies to describe AMN Healthcare Services:

  • It's like Robert Half, but exclusively focused on staffing nurses, doctors, and other medical professionals for hospitals and healthcare facilities.
  • Think of it as an 'Uber for healthcare professionals,' where hospitals can quickly find temporary or permanent nurses, doctors, and allied staff.

AI Analysis | Feedback

  • Nurse Staffing Solutions: Provides temporary and permanent placements for registered nurses, including travel, rapid response, and local nurse staffing.
  • Allied Health Staffing Solutions: Offers staffing for various allied health professionals such as physical therapists, respiratory therapists, and medical technologists.
  • Physician Staffing Solutions: Supplies temporary (locum tenens) and permanent physicians to healthcare facilities.
  • Healthcare Leadership & Executive Search: Places interim leaders and conducts executive searches for key leadership roles within healthcare organizations.
  • Revenue Cycle Solutions: Delivers services to help healthcare facilities optimize their financial processes and revenue management.
  • Language Services: Provides professional language interpretation and translation services specifically for the healthcare industry.
  • Healthcare Technology & Workforce Management: Offers vendor management systems, workforce optimization, telehealth, and credentialing solutions to manage healthcare staff and operations efficiently.

AI Analysis | Feedback

AMN Healthcare Services (AMN) sells its services primarily to other companies. Its major customers are institutions within the healthcare sector:

  • Hospitals: This includes large hospital systems, academic medical centers, community hospitals, and specialty hospitals across the United States.
  • Healthcare Facilities: This category encompasses a broad range of facilities such as physician groups, clinics, long-term care facilities, ambulatory surgery centers, urgent care centers, and other medical practices.
  • Other Healthcare Organizations: This may also include organizations seeking specialized services like interim leadership, executive search, revenue cycle solutions, language services, or technology solutions such as vendor management systems and workforce optimization.

Due to the nature of its business as a comprehensive staffing and workforce solutions provider to the broad healthcare industry, AMN Healthcare Services serves a highly diversified client base. The company typically serves thousands of healthcare organizations and does not publicly disclose a short list of specific named "major customer" companies, nor do individual customers usually represent a significant concentration of its revenue. Therefore, specific names and public symbols of customer companies cannot be provided.

AI Analysis | Feedback

null

AI Analysis | Feedback

Cary Grace, President & Chief Executive Officer

Cary Grace became the President and Chief Executive Officer of AMN Healthcare Services in November 2022. She previously served as the CEO of Global Retirement, Investment, and Human Capital at Aon, a significant organization in risk management, retirement, health, and human capital solutions. Her leadership at Aon included overseeing Global M&A integration and private health exchanges. Before joining Aon in 2011, Ms. Grace spent over 14 years at Bank of America (and more than 20 years combined at Bank of America and JPMorgan), where she led various institutional and private banking businesses. She has been recognized as one of the Most Powerful Women in Finance by American Banker.

Brian Scott, Chief Financial Officer & Chief Operating Officer

Brian Scott was appointed Chief Financial Officer and Chief Operating Officer, with his role effective November 21, 2024. He has a long history with AMN, having previously served as CFO and Chief Accounting Officer from January 2011 through August 2021. During his earlier tenure as CFO/Chief Accounting Officer at AMN, he was instrumental in driving substantial growth, including a fourfold increase in quarterly revenue and a 13x increase in adjusted EBITDA, largely due to several highly accretive acquisitions. Between his two periods at AMN, he served as CFO at Jack in the Box Inc. and also held CFO positions at healthcare service providers TheKey and ShiftKey. Mr. Scott serves on the Board of Community Care Partners, a private equity-backed operator of urgent care centers, and previously served on the Boards of Thriveworks and Hueman.

Whitney M. Laughlin, Corporate Secretary and Chief Legal Officer

Whitney M. Laughlin holds the positions of Corporate Secretary and Chief Legal Officer at AMN Healthcare. In this role, she is responsible for the company's legal affairs and corporate governance.

Mark Hagan, Chief Information and Digital Officer

Mark Hagan serves as the Chief Information and Digital Officer for AMN Healthcare. He leads the company's information technology and digital transformation initiatives.

Tomya Watt, Chief People Officer

Tomya Watt assumed the role of Chief People Officer at AMN Healthcare, effective January 13, 2025. Before joining AMN, she was the interim Chief Human Resources Officer and Chief Diversity Officer at Memorial Sloan Kettering Cancer Center, where she managed all HR functions for the 22,000-employee organization. Her background also includes senior leadership positions at Kelly Services Inc. and Comerica Bank.

AI Analysis | Feedback

Key Risks to the Business:

  1. Cyclicality in Demand for Healthcare Professionals and Staffing Services, and Persistent Shortages: The core business of AMN Healthcare Services is highly dependent on the demand for contingent and permanent healthcare talent, which is subject to significant fluctuations, as demonstrated by the "historic correction in the Healthcare contingent labor market since the end of the COVID pandemic". This cyclicality is further complicated by persistent, industry-wide shortages of healthcare professionals, including a projected deficit of over 78,000 full-time registered nurses by 2025, which poses a substantial challenge for sourcing and placement. The company's ability to quickly and efficiently credential and match qualified professionals with suitable placements is crucial, and any adverse changes in state or interstate licensing laws could negatively impact its operations.
  2. Intense Competitive Pressure and Client Concentration: AMN Healthcare Services operates in a highly competitive landscape, facing pressure from both established competitors (such as Aya, CHG, Cross Country, and Jackson) and new entrants. This competitive environment can lead to pricing pressures and a potential stagnation or loss of market share. Adding to this risk is a significant client concentration, with one major client, Kaiser, representing approximately 22% of the company's consolidated revenue in 2025. The loss of such a key client, or the increased negotiating leverage of consolidating healthcare delivery organizations, could have a material adverse effect on AMN's revenue, results of operations, and cash flows.
  3. Regulatory and Reimbursement Changes: As a provider of healthcare workforce solutions, AMN Healthcare Services is exposed to substantial risks arising from changes in government regulations and healthcare reimbursement policies within its operational markets. Shifts in these regulatory frameworks and reimbursement models can directly influence the demand for staffing services, the rates AMN can charge, and its overall profitability. Specifically, changes in state licensing laws or interstate compact laws related to healthcare professionals could impact the speed and cost of credentialing, thereby affecting the business.

AI Analysis | Feedback

The emergence of technology-driven gig economy platforms that directly connect healthcare professionals (e.g., nurses, allied staff) with healthcare facilities for temporary shifts. These platforms aim to disintermediate traditional staffing agencies like AMN Healthcare by offering professionals more control over their schedules and potentially higher compensation, while providing facilities with direct access to a flexible workforce, potentially at a lower cost, thereby challenging AMN's core business model as a staffing intermediary.

AI Analysis | Feedback

AMN Healthcare Services (symbol: AMN) operates within several significant addressable markets within the United States healthcare sector. The company provides a range of staffing and workforce solutions across three main segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The addressable market sizes for their key products and services in the U.S. are as follows:

Nurse and Allied Solutions

  • Overall U.S. Healthcare Staffing Market: The U.S. healthcare staffing market was estimated at approximately $45.48 billion in 2025 and is projected to reach $89.71 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 6.98% from 2026 to 2033. Other estimates for the U.S. healthcare staffing market in 2025 range from $20.6 billion to $22.81 billion.
  • Travel Nurse Staffing (U.S.): This segment is a dominant force within the U.S. healthcare staffing market, accounting for an estimated 40.53% of the revenue share in 2025. The market size for travel nursing is predicted to be around $19.5 billion in 2025.
  • Allied Health Staffing (U.S.): The allied healthcare staffing market in North America, which includes the U.S., was valued at $28.17 billion in 2025 and is expected to grow to $31.08 billion in 2026, with a CAGR of 10.3%. It is projected to reach $45.61 billion by 2030.

Physician and Leadership Solutions

  • Locum Tenens Staffing (U.S.): The U.S. locum tenens market reached an estimated $9.6 billion in 2025 and is projected to grow to $9.9 billion in 2026. Other estimates place the U.S. locum tenens staffing market size at approximately $9.5 billion in 2024, with projections to reach around $19.74 billion by 2034, growing at a CAGR of 7.59% from 2025 to 2034.
  • Physician Permanent Placement Solutions (U.S.): While a specific market size for permanent placement solutions alone was not identified, the broader U.S. Healthcare Physician Staffing Market (which includes locum tenens, permanent, and temporary staffing) was valued at $6.05 billion in 2024. It is expected to grow from $6.31 billion in 2025 to $9.6 billion by 2035, at a CAGR of 4.3% from 2025 to 2035.

Technology and Workforce Solutions

  • Healthcare Language Services (U.S.): North America is expected to lead the global healthcare language market, holding a 40.3% share in 2025. The global healthcare language market is estimated to be valued at $1.95 billion in 2025 and is expected to reach $3.68 billion by 2032, exhibiting a CAGR of 9.5% from 2025 to 2032. More specifically, the U.S. Medical Interpreter Services Market was valued at $30.84 million in 2024, projected to grow to $31.71 million by 2025 and exceed $42.44 million by 2034 with a CAGR of 2.8%.
  • Vendor Management Systems (VMS) and Workforce Optimization (Healthcare Workforce Management Systems - HWMS) (U.S.): The U.S. healthcare workforce management system market size was $670 million in 2024 and is projected to be worth around $1.53 billion by 2034, growing at a CAGR of 8.61% from 2025 to 2034. Another estimate for the U.S. market indicates it was $662.8 million in 2023 and is expected to reach $1.51 billion by 2030, with a CAGR of 12.5% from 2024 to 2030. Globally, the healthcare workforce management systems market is estimated at $2.29 billion in 2025 and is expected to reach $6.26 billion by 2035, growing at a CAGR of 10.60% from 2026 to 2035. North America held the largest revenue share, exceeding 40.16% in 2025.
  • Telehealth (U.S.): The U.S. telehealth market size reached approximately $52.77 billion in 2025 and is anticipated to increase to $65.35 billion in 2026. It is forecasted to achieve a value of around $447.69 billion by 2035, growing at a CAGR of 23.84%. Another report estimated the U.S. telehealth market revenue at $42.54 billion in 2024, expected to reach $150.13 billion by 2030, with a CAGR of 23.8% from 2025 to 2030.

AI Analysis | Feedback

AMN Healthcare Services (AMN) is expected to drive future revenue growth over the next two to three years through several key strategies and market dynamics:

  1. Stabilization and Recovery of the Healthcare Staffing Market: The healthcare staffing industry is anticipated to stabilize after a multi-year period of decline, with AMN Healthcare positioning itself for sustainable organic revenue growth of 4-6% per year following the normalization observed in 2023-2024. Management has indicated that the industry is returning to growth, which is expected to help the company regain momentum.
  2. Expansion of Technology and Workforce Solutions, including AI and VMS Platforms: AMN is strategically focusing on higher-margin, technology-centric solutions to drive revenue growth. This includes the rollout of its ShiftWise Flex platform, which surpassed 36% of its Vendor Management System (VMS) clients' spend in Q1 2024. The company is also leveraging AI enablement across recruiting, applicant tracking, credentialing, and support to improve efficiency, speed clinician matching, and cut time-to-fill for nursing roles.
  3. Growth in Managed Services Programs (MSPs): AMN is prioritizing and winning new, longer-duration Managed Services Program (MSP) contracts, which are crucial for stabilizing revenue. The company has a robust sales pipeline in MSP and has secured new MSP and vendor-neutral contracts, highlighting this as a core competitive advantage.
  4. Targeted Growth in High-Demand Clinical Segments and New Care Settings: The company is aiming for growth in specific service lines such as Allied International and Language Services, expecting them to return to year-over-year growth. Growth in locum tenens, partly driven by strategic acquisitions like MSDR, and the schools business within the Allied segment also contribute to this driver. Additionally, AMN is focusing on capturing demand in outpatient and post-acute care settings as the U.S. population ages.
  5. Revenue from Labor Disruption Events: While often unpredictable, labor disruption events have recently provided a significant boost to AMN's revenue. The company reported substantial labor disruption revenue in Q4 2025, which is projected to continue contributing significantly in Q1 2026. This demonstrates the company's capability to capitalize on urgent staffing needs during such events.

AI Analysis | Feedback

Capital Allocation Decisions for AMN Healthcare Services (AMN) Over the Last 3-5 Years

Share Repurchases

  • AMN Healthcare repurchased $425 million of its common stock in 2023.
  • The company's Board of Directors authorized an additional $250 million under its share repurchase program in June 2022, with approximately $326.3 million remaining under the program at that time.
  • The latest reported value for AMN's stock repurchases over the last twelve months was $175 million as of November 7, 2025.

Share Issuance

  • AMN Healthcare's share count has generally declined over the past few years.
  • While there are instances of shares issued due to the vesting of Restricted Stock Units (RSUs) for insiders, shares are also withheld for taxes, resulting in a minimal net impact on overall outstanding shares in recent quarters.

Outbound Investments

  • In November 2023, AMN Healthcare acquired MSDR, a healthcare staffing and locum tenens provider, for $300 million to strengthen its presence and capabilities in the locum tenens market.
  • The company acquired Connetics USA in May 2022 to enhance its market reach and international nurse recruiting capabilities.
  • AMN Healthcare completed the acquisition of Synzi in May 2021 for $42.5 million.

Capital Expenditures

  • AMN Healthcare's capital expenditures for the full year 2025 totaled $36 million, with $7.9 million reported in Q4 2025.
  • In 2023, nearly 50% of capital expenditures were directed toward new and enhanced digital programs to achieve productivity gains, market differentiation, and revenue growth.
  • Recent investments include the launch of the WorkWise healthcare technology platform in 2024 and expanded AI-driven features in the AMN Passport app for job matching and automated credential updates through 2025, aiming to improve efficiency and speed across operations.

Better Bets vs. AMN Healthcare Services (AMN)

Peer Outperformance in Health Care Services

AMN has trailed 100% of its 19 Health Care Services peers over 5Y. Health Care Services ranks 2nd of 10 industries in Health Care by median 5Y return. That makes it one of the strongest corners of the sector.
Share of Health Care Services constituents that AMN has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
1Y
86%
of 21 industry peers · 76.0% return
3Y
0%
of 19 industry peers · -60.4% return
5Y
0%
of 19 industry peers · -67.3% return
No Health Care Services peer with a comparable growth profile has beaten AMN by more than 20pp over 5Y.
Median price return by industry across the Health Care sector, ranked by 5Y. Health Care Services is AMN's own industry. Use this to see which corners of the sector have carried the returns.
Industry Names 1Y med3Y med5Y med Top 3 by 5Y
Health Care Distributors 7 8.4%80.2%137.8% CAH 410% · MCK 337% · COR 180%
Health Care Services ← 20 19.9%44.4%9.4% HIMS 337% · RDNT 147% · DGX 75%
Managed Health Care 8 32.1%-4.0%-0.3% OSCR 138% · HQY 65% · ELV 13%
Health Care Facilities 24 8.8%-3.9%-15.3% THC 270% · NHC 261% · ENSG 126%
Health Care Equipment 51 -1.1%-6.1%-17.6% POCI 11000% · UFPT 381% · GKOS 287%
Health Care Supplies 12 38.2%-12.0%-25.7% LNTH 302% · HAE 82% · MMSI 33%
Pharmaceuticals 63 7.3%0.7%-29.1% LQDA 2808% · INDV 1373% · ETON 1294%
Life Sciences Tools & Services 108 -0.5%-31.3%-70.9% SNWV 1990% · ELMD 257% · MEDP 241%
Health Care Technology 20 -23.4%-53.0%-73.9% SPOK 118% · HSTM -3% · VEEV -22%
Biotechnology 366 17.1%-23.9%-76.7% BRTX 106550% · DNTH 1652% · CELZ 1500%
Median of constituents with a full price history over each window. Top names are unfiltered by size in this render.

Latest Trefis Analyses

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

AMNHSTMKFYMedian
NameAMN Heal.HealthSt.Korn Fer. 
Mkt Price35.3228.5584.4035.32
Mkt Cap1.40.84.41.4
Rev LTM3,4343212,8902,890
Op Inc LTM16126378161
FCF LTM43942288288
FCF 3Y Avg30037273273
CFO LTM47172373373
CFO 3Y Avg36467339339

Growth & Margins

AMNHSTMKFYMedian
NameAMN Heal.HealthSt.Korn Fer. 
Rev Chg LTM24.0%8.8%5.4%8.8%
Rev Chg 3Y Avg-5.5%5.5%0.5%0.5%
Rev Chg Q2.3%12.5%7.2%7.2%
QoQ Delta Rev Chg LTM0.4%3.0%1.7%1.7%
Op Inc Chg LTM173.6%20.3%15.5%20.3%
Op Inc Chg 3Y Avg15.2%29.1%-0.0%15.2%
Op Mgn LTM4.7%8.0%13.1%8.0%
Op Mgn 3Y Avg4.4%7.3%11.5%7.3%
QoQ Delta Op Mgn LTM0.6%0.5%0.2%0.5%
CFO/Rev LTM13.7%22.4%12.9%13.7%
CFO/Rev 3Y Avg11.5%22.2%12.0%12.0%
FCF/Rev LTM12.8%13.0%10.0%12.8%
FCF/Rev 3Y Avg9.4%12.2%9.7%9.7%

Valuation

AMNHSTMKFYMedian
NameAMN Heal.HealthSt.Korn Fer. 
Mkt Cap1.40.84.41.4
P/S0.42.61.51.5
P/Op Inc8.632.311.511.5
P/EBIT6.932.311.011.0
P/E13.139.416.216.2
P/CFO2.911.611.711.6
Total Yield7.6%3.0%8.5%7.6%
Dividend Yield0.0%0.5%2.3%0.5%
FCF Yield 3Y Avg25.8%4.5%7.7%7.7%
D/E0.60.00.10.1
Net D/E0.3-0.1-0.1-0.1

Returns

AMNHSTMKFYMedian
NameAMN Heal.HealthSt.Korn Fer. 
1M Rtn4.6%0.9%8.2%4.6%
3M Rtn31.5%19.5%28.4%28.4%
6M Rtn106.8%43.4%37.0%43.4%
12M Rtn76.0%8.2%18.0%18.0%
3Y Rtn-60.4%34.5%76.2%34.5%
1M Excs Rtn0.6%0.0%5.5%0.6%
3M Excs Rtn26.4%12.2%25.3%25.3%
6M Excs Rtn94.8%31.4%25.0%31.4%
12M Excs Rtn62.3%-11.9%-0.6%-0.6%
3Y Excs Rtn-132.4%-39.5%1.1%-39.5%

Comparison Analyses

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Nurse and Allied Solutions1,6471,8162,6253,9822,990
Physician and Leadership Solutions696729670698594
Technology and Workforce Solutions387439495563400
Total2,7302,9843,7895,2433,984


Operating Income by Segment
$ Mil20252024202320222021
Technology and Workforce Solutions126174215299188
Nurse and Allied Solutions126174362576461
Physician and Leadership Solutions5779959281
Gain on sale of disposal group39    
Depreciation (included in cost of revenue)-9-7-6-4-3
Long-lived assets impairment loss-18 -8  
Share-based compensation-31-23-18-30-25
Unallocated corporate overhead-88-110-147-154-123
Goodwill impairment losses-110-222   
Depreciation and amortization-148-167-155-133-101
Total-55-103338647478


Price Behavior

Price Behavior
Market Price$35.32 
Market Cap ($ Bil)1.4 
First Trading Date11/13/2001 
Distance from 52W High-3.5% 
   50 Days200 Days
DMA Price$32.74$23.16
DMA Trendupup
Distance from DMA7.9%52.5%
 3M1YR
Volatility61.8%68.3%
Downside Capture40.7179.22
Upside Capture159.70126.74
Correlation (SPY)4.9%17.1%
AMN Betas & Captures as of 7/31/2026

 1M2M3M6M1Y3Y
Beta-0.07-0.230.620.750.860.77
Up Beta-0.44-0.02-0.15-0.770.330.63
Down Beta0.22-0.71-0.271.071.380.95
Up Capture28%41%259%196%124%17%
Bmk +ve Days11223567138427
Stock +ve Days12263669123352
Down Capture-32%-61%6%73%67%102%
Bmk -ve Days11212859114326
Stock -ve Days10172757129398

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with AMN
AMN82.2%68.2%1.14-
Sector ETF (XLV)31.1%15.8%1.5116.3%
Equity (SPY)20.7%12.8%1.1917.0%
Gold (GLD)35.0%28.8%1.043.4%
Commodities (DBC)41.4%20.2%1.60-4.4%
Real Estate (VNQ)15.3%13.9%0.7816.5%
Bitcoin (BTCUSD)-44.7%42.7%-1.274.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with AMN
AMN-19.1%53.2%-0.20-
Sector ETF (XLV)7.6%15.1%0.3126.5%
Equity (SPY)13.1%17.2%0.5924.5%
Gold (GLD)20.4%18.6%0.89-0.0%
Commodities (DBC)9.8%19.6%0.393.4%
Real Estate (VNQ)2.4%18.9%0.0324.1%
Bitcoin (BTCUSD)7.2%52.6%0.3210.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with AMN
AMN-0.2%47.2%0.17-
Sector ETF (XLV)10.8%16.7%0.5327.5%
Equity (SPY)15.2%17.9%0.7228.9%
Gold (GLD)12.5%16.2%0.630.4%
Commodities (DBC)7.9%18.1%0.357.0%
Real Estate (VNQ)4.9%20.7%0.2025.1%
Bitcoin (BTCUSD)60.0%66.0%1.007.5%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date7312026
Short Interest: Shares Quantity3.4 Mil
Short Interest: % Change Since 7152026-6.0%
Average Daily Volume0.6 Mil
Days-to-Cover Short Interest5.4 days
Basic Shares Quantity39.0 Mil
Short % of Basic Shares8.7%

Earnings Returns History

Updated 8/6/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/6/2025-3.0%-12.8%-13.5%
8/7/20251.9%10.3%24.3%
5/8/20258.2%10.1%5.1%
2/20/20256.7%2.8%-6.8%
11/7/2024-29.0%-41.7%-31.4%
8/8/2024-6.5%-16.6%-26.5%
5/9/2024-10.1%-2.9%-13.6%
2/15/2024-20.5%-29.3%-19.0%
...
SUMMARY STATS   
# Positive969
# Negative111411
Median Positive6.7%10.1%6.5%
Median Negative-9.2%-7.0%-13.6%
Max Positive12.2%16.8%24.3%
Max Negative-29.0%-41.7%-31.4%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/6/2025-3.0%-12.8%-13.5%
8/7/20251.9%10.3%24.3%
5/8/20258.2%10.1%5.1%
2/20/20256.7%2.8%-6.8%
11/7/2024-29.0%-41.7%-31.4%
8/8/2024-6.5%-16.6%-26.5%
5/9/2024-10.1%-2.9%-13.6%
2/15/2024-20.5%-29.3%-19.0%
11/2/2023-7.7%-16.7%0.3%
8/3/2023-11.6%-10.9%-13.8%
5/4/20236.8%10.0%17.2%
2/16/2023-5.1%-5.6%-14.2%
11/3/2022-9.2%-3.5%-3.1%
8/4/20228.9%4.7%-6.7%
5/5/2022-1.4%-8.5%6.5%
2/17/202212.2%16.8%12.6%
11/4/2021-13.1%-3.5%-1.1%
8/5/20210.1%-0.9%9.6%
5/6/20211.9%-1.6%6.3%
2/18/20215.3%-1.8%2.5%
SUMMARY STATS   
# Positive969
# Negative111411
Median Positive6.7%10.1%6.5%
Median Negative-9.2%-7.0%-13.6%
Max Positive12.2%16.8%24.3%
Max Negative-29.0%-41.7%-31.4%

SEC Filings

Expand for More
Report DateFiling DateFiling
06/30/202608/07/202610-Q
03/31/202605/08/202610-Q
12/31/202502/20/202610-K
09/30/202511/07/202510-Q
06/30/202508/08/202510-Q
03/31/202505/09/202510-Q
12/31/202402/21/202510-K
09/30/202411/08/202410-Q
06/30/202408/09/202410-Q
03/31/202405/10/202410-Q
12/31/202302/22/202410-K
09/30/202311/06/202310-Q
06/30/202308/04/202310-Q
03/31/202305/05/202310-Q
12/31/202202/22/202310-K
09/30/202211/04/202210-Q
Collapse to Preview
Report DateFiling DateFiling
06/30/202608/07/202610-Q
03/31/202605/08/202610-Q
12/31/202502/20/202610-K
09/30/202511/07/202510-Q
06/30/202508/08/202510-Q
03/31/202505/09/202510-Q
12/31/202402/21/202510-K
09/30/202411/08/202410-Q
06/30/202408/09/202410-Q
03/31/202405/10/202410-Q
12/31/202302/22/202410-K
09/30/202311/06/202310-Q
06/30/202308/04/202310-Q
03/31/202305/05/202310-Q
12/31/202202/22/202310-K
09/30/202211/04/202210-Q
06/30/202208/05/202210-Q
03/31/202205/06/202210-Q
12/31/202102/24/202210-K
09/30/202111/05/202110-Q
06/30/202108/06/202110-Q
03/31/202105/10/202110-Q
12/31/202002/26/202110-K
09/30/202011/06/202010-Q
06/30/202008/10/202010-Q
03/31/202005/11/202010-Q
12/31/201902/25/202010-K
09/30/201911/04/201910-Q

Insider Activity

Updated 7/9/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Foletta, Mark G by TrustSell616202631.073,681114,362556,647Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Foletta, Mark G by TrustSell616202631.073,681114,362556,647Form

Investor Activity (13F)

Updated Aug 20, 2026
13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Medina Value Partners, LLC$10.0 Mil2.1%30New13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Medina Value Partners, LLC$10.0 Mil2.1%30New13F
Active Manager
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Medina Value Partners, LLC$10.0 Mil2.1%30New13F
Core Cache Last Updated: 8/19/2026